Macomics secures £3.2m of seed funding

A NEW University of Edinburgh spin-out has launched with £3.2 million of seed funding to develop immunotherapies targeting cancer tumours.

Macomics is founded on research from the laboratory of Jeffrey Pollard, director of the MRC Centre for Reproductive Health. Together with Macomics co-founder Luca Cassetta, they have produced decades of research into the role of macrophages in increasing the body’s immune defence against tumours.

The seed funding has been provided by transatlantic scientific investor Epidarex Capital and the Scottish Investment Bank. The cash is expected to fund an initial 18 months of work before Macomics embarks on its next funding round.

Macomics has also announced the appointment of biotechnology industry expert Robert Haigh as chief executive, and Jane Dancer as a non-executive director.

Mr Pollard said:  “The creation of Macomics based on the research of my group at the University of Edinburgh provides the team with an exciting opportunity to develop new effective cancer drugs against macrophage targets that will bring real clinical benefit to many more patients suffering from cancer.”

Sponsor

Our Other Titles

Latest

Former IBM Greencok site cleared ahed of potential £100m rejuvenation

GROUNDWORK to prepare the historic IBM Greenock site for a potential £100million residential and commercial transformation has begun in earnest.

Continued growth for Addleshaw Goddard in Scotland

DESPITE a challenging period, Addleshaw Goddard has continued to see growth in Scotland, the rest of the UK and internationally with revenues...

Anti-counterfeit team set up by Scottish IP firm to tackle scourge of replica goods

A SPECIALIST anti-counterfeiting team has been created by IP firm Marks & Clerk in response to the growing counterfeit goods trade, which...

Logan Energy gets hydrogen on the road in multi-million pound Teesside project

EDINBURGH-based hydrogen technology specialist, Logan Energy, has been chosen as the preferred partner to supply two of the first publicly-accessible hydrogen refuelling...

Orbis Protect acquires Glasgow-based Optosafe

GLASGOW-based Optosafe has been acquired by Orbis Protect. The deal comes comes following a sustained growth in Orbis Protect...